Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

Share Price is delayed by 15 minutes
Get Live Data
440.00    2.00 (0.46%)
Bid:
435.00
Ask:
443.00
Spread: 8.00 (1.839%)
Market Cap: £217.24m
CLIG Live PriceLast checked at - London Stock Exchange

Intraday City Lon Inv Share Chart

Funds Under Management - 31/3/22 - Trading Update

26 Apr 2022 07:00

RNS Number : 2764J
City of London Investment Group PLC
26 April 2022
Β 

City of London Investment Group PLC

26 April 2022

ο»Ώ

CITY OF LONDON INVESTMENT GROUP PLC

("City of London", "the Group" or "the Company")

Β 

FUNDS UNDER MANAGEMENT ("FuM") AS AT 31 March 2022,

TRADING UPDATE

Β 

City of London (LSE: CLIG), a leading specialist asset management group offering a range of institutional and retail products investing primarily in closed-end funds, announces that on a consolidated basis, as at 31 March 2022, FuM were US$10.3 billion (Β£7.8 billion). This compares with US$11.1 billion (Β£8.2 billion) as at 31 December 2021. A breakdown by strategy follows:

Β 

FuM ($ million)

Strategy Index

Mar-22

Dec-21

%

Net

%

(estimate)

inc/dec

Flows

inc/dec

EM

4,221

4,800

-12%

31

MSCI EM Net TR

-7.0%

KIM

3,766

3,949

-5%

(13)

Not applicable

INTL

1,950

2,147

-9%

39

MSCI ACWI ex US

-5.4%

OV

225

232

-3%

11

ACWI/Barclays Global Agg

-5.7%

Other*

103

22

361%

79

10,265

11,150

147

* includes Frontier, REIT and seed investments

FuM figures are rounded

Β 

During the period under review, CLIG flows were positive with net inflows of circa US$147 million across the Group's strategies. With regard to business development, the Group continues to maintain an active pipeline across all of its major Closed-End Fund ("CEF") offerings with an increased interest in the diversification CEF strategies.Β 

Β 

IM Performance

Β 

Both absolute and relative performance was weak across CLIM's investment strategies during the period. The EM strategy was impacted by the Russian invasion of Ukraine and both country allocation and NAV performance detracted in this regard. The CLIM International strategy underperformed due to poor NAV performance and widening discounts. KIM's investment strategies had positive relative performance.

Β 

Operations

Β 

The Group's income currently accrues at a weighted average rate of approximately 71 basis points of CLIM's FuM and at approximately 76 basis points of KIM's FuM, net of third party commissions. "Fixed" costs are c.Β£1.6 million per month, and accordingly the post-merger run-rate for operating profit, before profit-share is approximately Β£3.0 million per month based upon current FuM and a US$/Β£ exchange rate of US$1.3138 to Β£1 as at 31 March 2022.

Β 

Dividend

Β 

Interim dividend of 11 pence per share and a special dividend of 13.5p per share were paid on 25 March 2022. The Board will announce the final dividend on Tuesday 19 July 2022 in its pre-close trading update. For further information, please visit http://www.clig.co.uk/ or contact:

Β 

Tom Griffith, CEO

City of London Investment Group PLC

Tel: 001-610-380-0435

Β 

Martin Green

Zeus Capital Limited

Financial Adviser & Broker

Tel: +44 (0)20 3829 5000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTPPUCACUPPGMA
Date   Source Headline
15th Jun 20263:05 pmRNSEBT Share Purchase
20th Apr 20267:00 amRNSTrading Update for the quarter to 31 March 2026
7th Apr 20262:44 pmRNSPDMR Shareholding
31st Mar 20261:56 pmRNSEBT Share Purchase
26th Mar 202612:09 pmRNSEBT Share Purchase
25th Mar 202611:33 amRNSPDMR Shareholding
24th Mar 20269:56 amRNSEBT Share Purchase
13th Mar 20263:05 pmRNSPDMR Shareholding
10th Mar 20264:07 pmRNSEBT Share Purchase
10th Mar 20264:07 pmRNSEBT Share Purchase
9th Mar 202612:35 pmRNSPDMR Shareholding
4th Mar 202612:48 pmRNSGrant of LTIP Award
24th Feb 20267:00 amRNSHalf Year Results and Dividend Declaration
13th Feb 202611:00 amRNSInvestor Presentation
21st Jan 20267:00 amRNSAppointment of Chief Executive Officer
19th Jan 20267:00 amRNSTrading Update - Six months to 31 December 2025
29th Oct 20253:15 pmRNSPDMR/PCA Shareholding
29th Oct 20253:15 pmRNSPDMR Shareholding
29th Oct 20253:15 pmRNSPDMR Shareholding
29th Oct 20253:15 pmRNSPDMR Shareholding
27th Oct 20255:25 pmRNSResult of AGM
21st Oct 20255:00 pmRNSPDMR Shareholding
20th Oct 20257:00 amRNSTrading Update - Quarter to 30 September 2025
22nd Sep 20255:20 pmRNSCorrection: Final Results for year to 30 June 25
16th Sep 20257:00 amRNSFinal Results for the year to 30th June 2025
11th Sep 20257:00 amRNSInvestor Presentation via Investor Meet Company
5th Aug 20258:14 amRNSDirector Declaration
24th Jul 20257:00 amRNSPre-Close Trading Update
2nd Jul 20256:12 pmRNSBoard and Committee changes
1st Jul 202512:10 pmRNSDirector/PDMR Shareholding
17th Jun 20255:34 pmRNSDirector/PDMR Shareholding
13th Jun 20259:57 amRNSDirector/PDMR Shareholding
13th Jun 20259:47 amRNSHolding(s) in Company
10th Jun 20257:00 amRNSDirectorate Change
22nd Apr 20257:00 amRNSFUNDS UNDER MANAGEMENT 31 MARCH 25, TRADING UPDATE
7th Apr 20257:00 amRNSAPPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR
25th Feb 20257:00 amRNSHalf Year Results
20th Jan 20257:00 amRNSSIX MONTHS TO 31 DECEMBER 2024 TRADING UPDATE
29th Oct 20245:27 pmRNSPDMR Dealing
29th Oct 20245:27 pmRNSPDMR Dealing
29th Oct 20245:26 pmRNSPDMR Dealing
28th Oct 20245:57 pmRNSResult of AGM & Board change - Replacement
28th Oct 20244:14 pmRNSResult of AGM and Board and Committee change
21st Oct 20247:00 amRNSTRADING UPDATE - Quarter to 30 September 2024
17th Oct 20244:46 pmRNSHolding(s) in Company
16th Oct 20241:02 pmRNSHolding(s) in Company
11th Oct 20244:50 pmRNSHolding(s) in Company
24th Sep 20247:00 amRNSFINAL RESULTS FOR THE YEAR TO 30TH JUNE 2024
13th Sep 20242:54 pmRNSFull Year Results release date
25th Jul 20247:00 amRNSPRE-CLOSE TRADING UPDATE

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.